Literature DB >> 11616801

The safety and efficacy of new drug approval.

D H Gieringer.   

Abstract

Mesh:

Year:  1985        PMID: 11616801

Source DB:  PubMed          Journal:  Cato J        ISSN: 0273-3072


× No keyword cloud information.
  5 in total

Review 1.  Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs).

Authors:  Win Min Oo; David J Hunter
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-20       Impact factor: 3.625

2.  Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the "Right to Try".

Authors:  Gail A Van Norman
Journal:  JACC Basic Transl Sci       Date:  2018-05-30

3.  The FDA and the COVID-19: A political economy perspective.

Authors:  Raymond J March
Journal:  South Econ J       Date:  2021-02-28

4.  Perceptions of Regulatory Decision-Making for New Drugs From the Viewpoints of the Manufacturers in South Korea.

Authors:  Kyung-Bok Son; Sylvia Park
Journal:  Front Med (Lausanne)       Date:  2022-03-30

5.  Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs.

Authors:  Gail A Van Norman
Journal:  JACC Basic Transl Sci       Date:  2016-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.